Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Childhood cancer survivor hosts 11th annual Larger Than Cancer celebration, honoring fellow pediatric cancer patients.

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

Shares of Enliven Therapeutics were sharply higher after the biotechnology company reported positive initial data from a Phase 1b trial for a leukemia treatment. The stock was up 61% at $24.95 in ...

PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA ...

A new Yale-led study published Thursday identified a new target for treating the most common form of cancer in children and ...

"They did the blood tests, and they came back ‘a bit spicy’—the doctor’s words," mom Elle Rugari told Newsweek.

Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...

The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...